What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
Ron Waksman mainly focuses on Internal medicine, Surgery, Cardiology, Myocardial infarction and Stent.
The concepts of his Surgery study are interwoven with issues in Stenosis, Valve replacement and Revascularization.
His studies link Retrospective cohort study with Cardiology.
His Myocardial infarction research incorporates themes from Prospective cohort study and Ejection fraction.
His Stent study integrates concerns from other disciplines, such as Discontinuation, Drug and Sirolimus.
His research investigates the link between Percutaneous coronary intervention and topics such as Conventional PCI that cross with problems in Emergency medicine.
His most cited work include:
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. (1287 citations)
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate (956 citations)
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. (939 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Surgery, Percutaneous coronary intervention and Myocardial infarction.
His study in the field of Stent, Valve replacement, Coronary artery disease and Transcatheter aortic also crosses realms of In patient.
He does research in Stent, focusing on Restenosis specifically.
His Cardiology study often links to related topics such as Percutaneous.
His studies in Surgery integrate themes in fields like Aortic valve replacement and Drug.
His Percutaneous coronary intervention study combines topics from a wide range of disciplines, such as Clopidogrel, Conventional PCI and Emergency medicine.
He most often published in these fields:
- Internal medicine (56.54%)
- Cardiology (53.12%)
- Surgery (31.44%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (56.54%)
- Cardiology (53.12%)
- Percutaneous coronary intervention (27.85%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Percutaneous coronary intervention, Surgery and Transcatheter aortic.
His work in the fields of Internal medicine, such as Myocardial infarction, Coronary artery disease, Revascularization and Coronavirus disease 2019, overlaps with other areas such as In patient.
His Cohort research extends to Cardiology, which is thematically connected.
Ron Waksman has included themes like Intravascular ultrasound, Radiology and Conventional PCI in his Percutaneous coronary intervention study.
His Surgery study frequently draws connections to other fields, such as Clinical trial.
His study in Stent is interdisciplinary in nature, drawing from both Drug and Sirolimus.
Between 2017 and 2021, his most popular works were:
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification (159 citations)
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention (133 citations)
- Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis (109 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cardiology
Ron Waksman spends much of his time researching Internal medicine, Cardiology, Percutaneous coronary intervention, Surgery and Valve replacement.
In general Cardiology study, his work on Acute coronary syndrome often relates to the realm of In patient, thereby connecting several areas of interest.
His work carried out in the field of Percutaneous coronary intervention brings together such families of science as Coronary artery disease, Stent, Conventional PCI and Sirolimus.
His Stent research is mostly focused on the topic Restenosis.
His biological study spans a wide range of topics, including Clinical trial and Target lesion.
His Valve replacement research is multidisciplinary, incorporating perspectives in Transcatheter aortic, Aortic valve stenosis, Aortic valve and Stroke.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
